News & Analysis on Clinical Trial Services & Contract Research And Development
Franco-German drugmaker Aventis has confirmed that it is seeking to delay the divestment of its stake in the loss-making chemicals major Rhodia, on the grounds that this willwreak havoc on the latter's restructuring drive.
For the second time this year, Germany's LION bioscience has dropped its full-year sales targets after reporting a slump in interim sales to €7.5 million.
The completion of Degussa's reorganisation of its fine chemicals activities into two separate business units heralds a raft of new projects at the company.
MWG links up with Quanta Biotech to launch a new offensive on the market for thermal cyclers, often described as a "must-have" laboratory tool. The deal also marks MWG's first entry into real-time thermal cyclers.
A partnership has been formed between Krauss-Maffei Process Technology UK and Buss-SMS, an international supplier of thermal separation solutions for difficult to handle mixtures.
A case study based on Pfizer's blockbuster antidepressant Zoloft (sertraline HCl) reveals how early research on the different crystal forms of a drug can avoid generic challenges later on.
The REACH framework for chemicals will contrary to the industry's view, actually improve conditions for innovation in Europe, according to EU Commissioner Erkki Liikanen.
Instruments specialist Mettler Toledo reports flat sales in a difficult operating environment for the sector, but says that investments in R&D should pay off going forward.
Researchers in the UK have uncovered important clues about how cells age that could be used to develop treatments that counteract the ability of cancers to grow and spread.